1. Home
  2. Analysis
  3. Moviprep
  4. Celebrex

Moviprep and Celebrex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 34 people who take Moviprep and Celebrex. Common interactions include anaemia macrocytic among females, and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people who take Moviprep and Celebrex have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 03, 2023

34 people who take Moviprep and Celebrex together, and have interactions are studied.

What is Moviprep?

Moviprep has active ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. It is used in colonoscopy abnormal. Currently, eHealthMe is studying from 3,096 Moviprep users.

What is Celebrex?

Celebrex has active ingredients of celecoxib. It is used in arthritis. Currently, eHealthMe is studying from 146,838 Celebrex users.

Number of Moviprep and Celebrex reports submitted per year:

Moviprep and Celebrex drug interactions.

Common Moviprep and Celebrex drug interactions by gender *:

female:

  1. Anaemia macrocytic
  2. Aplastic anaemia
  3. Arthralgia
  4. Asthenia
  5. Bladder disorder
  6. Cardio-respiratory arrest
  7. Cardiogenic shock
  8. Coma
  9. Drug ineffective
  10. General physical health deterioration

male:

  1. Chronic kidney disease
  2. Renal failure
  3. Amnesia
  4. Balance disorder
  5. Cerebrovascular accident
  6. Cognitive disorder
  7. Convulsion
  8. Deafness unilateral
  9. Depression
  10. Dizziness

Common Moviprep and Celebrex drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Brain stem haemorrhage

20-29:

  1. Intestinal obstruction

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Anxiety
  3. Depression
  4. Gout
  5. Mental disorder
  6. Panic attack
  7. Renal failure
  8. Renal impairment
  9. Tubulointerstitial nephritis
  10. Gastrooesophageal reflux disease

50-59:

  1. Musculoskeletal stiffness
  2. Nasal dryness
  3. Nasal obstruction
  4. Nasal polyps
  5. Nausea
  6. Night sweats
  7. Poor quality sleep
  8. Pyrexia
  9. Snoring
  10. Spinal pain

60+:

  1. Asthenia
  2. General physical health deterioration
  3. Confusional state
  4. Deafness unilateral
  5. Diarrhoea
  6. Dizziness
  7. Dysphagia
  8. Escherichia urinary tract infection
  9. Eye movement disorder
  10. Faecaloma

Common conditions people have *:

  1. Pain: 12 people, 35.29%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 29.41%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 26.47%
  4. High Blood Cholesterol: 6 people, 17.65%
  5. Constipation: 5 people, 14.71%
  6. Nausea (feeling of having an urge to vomit): 5 people, 14.71%
  7. Indigestion: 4 people, 11.76%
  8. Depression: 4 people, 11.76%
  9. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 11.76%
  10. Thyroid Diseases: 4 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Moviprep and Celebrex?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Moviprep drug interactions:

Browse interactions between Moviprep and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Celebrex drug interactions:

Browse interactions between Celebrex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate and celecoxib (the active ingredients of Moviprep and Celebrex, respectively), and Moviprep and Celebrex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Moviprep and Celebrex.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.